ABPI
UK pharma made £41 million in doctor payments
July 16, 2015Medical Communications, Sales and Marketing ABPI, ABPI Code, doctor payments
The pharma industry made £41m in payments to doctors, nurses and other healthcare professionals in the UK in 2014, the …
Pharma underwrites medicines bill with £207 million
June 8, 2015Manufacturing and Production, Sales and Marketing ABPI, NHS, PPRS, ahsn, brett wells
The Department of Health and the ABPI have confirmed a payment of £207 million from pharma to underwrite growth of …
NICE sets out office for market access plans
May 28, 2015Sales and Marketing ABPI, EMA, NHS, NICE, eams, market access
The UK healthcare watchdog NICE is to set up a new office for market access to advise pharma companies on …
Otsuka, ViiV and AstraZeneca named in ABPI code complaints
May 26, 2015Medical Communications, Research and Development, Sales and Marketing ABPI, AstraZeneca, Otsuka, PMCPA, ViiV
A ‘senior male employee’ of Otsuka Pharmaceuticals “potentially brought the industry into disrepute” by plying a female healthcare professional with …
After the UK general election, what’s next for pharma?
May 26, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BIA, election, medcity
In May the UK went to the polls and elected a Conservative government to replace the coalition that had been …
Chiesi rapped for ABPI code breach
May 7, 2015Medical Communications, Sales and Marketing ABPI, Chiesi, PMCPA
Chiesi made its sales reps go through a ‘tick-box’ compliance training exercise to get the pharma industry regulator ‘off its …
ABPI appoints head of medical affairs from GSK
May 6, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Jacintha Sivarajah, acha
The ABPI has appointed Dr Jacintha Sivarajah as the body’s new head of medical affairs. Reporting directly to its executive …
What you need to know about the EU Clinical Trial Regulation
April 20, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, EU Clinical Trial Regulation, EU-CTR, Virginia Acha
Where did the EU Clinical Trial Regulation come from? The EU Clinical Trial Regulation (EU-CTR) was approved in April 2014 …
Funding boost for UK drugs manufacturing
March 30, 2015Manufacturing and Production, Sales and Marketing ABPI, AstraZeneca, BIA, Bristol-Myers Squibb, Britest, Cambridge, Cambridge Crystallographic Data Centre, GlaxoSmithKline, Perceptive Engineering, Pfizer, Process Systems Enterprise, UCB, University of Leeds, amsci, mmip, stfc
The UK government is funding new manufacturing partnerships that will improve design processes and supply chain initiatives to lift the …
Pharma pays £310 million underwriting UK meds bill
March 13, 2015Sales and Marketing ABPI, NHS, PPRS, body, department, health pricing, pharma
Pharma has made a fourth quarter payment of £81 million to underwrite the 2014 UK medicines bill under the Pharmaceutical …
New details of Innovative Medicines review disclosed
March 11, 2015Research and Development, Sales and Marketing ABPI, NHS, NICE, PPRS, UK, george freeman, innovative medicines
The government has announced details of a sweeping review into how medicines are accessed in the UK. The Innovative Medicines …
Chiesi reprimanded again over Fostair drug
March 3, 2015Manufacturing and Production, Medical Communications, Sales and Marketing ABPI, Chiesi, PMCPA, code, formoterol/beclometason, fostair
Chiesi has been reprimanded after it breached the ABPI’s Code of Practice for its promotion of asthma inhaler Fostair. The …
Boehringer’s beer breach at German congress
February 20, 2015Medical Communications, Sales and Marketing ABPI, Boehringer, ERS, IPF, PMCPA, breach, code, munich
A complaint made by a pulmonologist against the competence of Boehringer Ingelheim speakers during a congress held in Germany last …
NICE is ‘setting prices too high’ for NHS
February 19, 2015Sales and Marketing ABPI, NHS, NICE, QALY, costs, health, pharma
The cost threshold NICE uses when approving drugs is too high and is doing more harm than good, new research …
UK pharma commits at least ‘one code breach a week’
February 18, 2015Medical Communications, Sales and Marketing ABPI, AstraZeneca, Bayer, Eli Lilly, GSK, Novartis, Novo Nordisk, PMCPA, Pfizer, code
Pharma companies commit unethical marketing practices on average more than once a week in the UK academic analysis has found. …
Latest content
FibroFind appoints Lee Borthwick as CEO
